Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

U.S. clinical stroke trial supports efficacy and safety of citicoline

Nov. 6, 1997

Patient enrollment complete for phase II trial of memantine

Nov. 6, 1997

FDA approves generic formulation of oxycodone/acetaminophen

Nov. 6, 1997

First market introduction for dolasetron

Nov. 6, 1997

New alpha2-adrenoceptor agonists from Synaptic

Nov. 5, 1997

New glycine-site NMDA partial agonist from ADIR

Nov. 5, 1997

MCI-186: Mitsubishi Chemical's new candidate for acute stroke

Nov. 5, 1997

Sequana and Parke-Davis collaborate on drug discovery for CNS

Nov. 5, 1997

U.S. patent issued for ABS 200 series

Nov. 4, 1997

Effects of riluzole on ischemia-induced glutamate accumulation in rabbits

Nov. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...